Leerink Partners analyst Mike Kratky downgrades Shockwave Medical (NASDAQ:SWAV) from Outperform to Market Perform and lowers the price target from $361 to $335.
Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.